References
- Manuel R, Pilar B, Xavier M. Systemin and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021;15:80–96.
- Tang L, Hu Y. Haemophagocytic lumphohisitiocytosis after COVID-19 vaccination. J Hematol Oncol. 2021;14(1):87.
- Dash S, Behera B, Sethy M, et al. COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther. 2021;34(5):e15093.
- Sjöwall C, Mandl T, Skattum L, et al. Epidemiology of hypocomplementaemic urticarial vasculitis. Rheumatology. 2018;57(8):1400–1407.
- Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol. 2000;12(1):24–31.
- Koc E, Aksoy B, Taliparmak A. Urtiarial vasculitis [Internet]; 2017 [cited 2020 Jun 17]. Available from: https://www.intechopen.com/books/a-comprehensive-review-of-urticaria-and-angioedema/urticarial-vasculitis
- Boyer A, Gautier N, Comoz F, et al. Nephropathy associated with hypocomplementic urticarial vasculitis: a case report and literature. Nephrol Ther. 2020;16(2):124–135.
- Venzor J, Lee WL, Huston DP. Urticarial vasculitis. Clin Rev Allergy Immunol. 2002;23(2):201–216.
- Buck A, Christensen J, Mccarty M. Hypocomplementic urticarial vacuities syndrome: a case-report and literature review. J Clin Aesthet Dermal. 2012;5(1):36–46.
- Dincy CV, George R, Jacob M, et al. Clinicpathologic profile of normocomplementic and hypocomplementic urticarial vasculitis: a study from South India. J Eur Acad Dermal Venereol. 2020;34(10):e566–e568.
- Kolkhir P, Grakhova M, Bonnekoh H, et al. Treatment of urticarial vasculitis: a systematic review. J Allergy Clin Immunol. 2019;143(2):458–466.
- Zuberbier T, Maurer M. Urticarial vasculitis and schnitzler syndrome. Immunol Allergy Clin North Am. 2014;34(1):141–147.
- Damman J, Mooyaart AL, Seelen MAJ, et al. Dermal C4d deposition and neutrophil alignment along the dermal-epidermal junction as a diagnostic adjunct for hypocomplementic urticarial vasculitis (anti-C1q vasculitis) and underlying systemic disease. Am J Dermatopathol. 2020;42(6):399–406.
- Kamyab K, Ghodsi SZ, Ghanadan A, et al. Eosinophilic infiltration: an under-reported histological findings in urticarial vasculitis. Int J Dermatol. 2019;58(7):825–829.
- Stephanie L, Gu BS, Joseph L, et al. Urticarial vasculitis. Int J Womens Dermatol. 2021;7(3):290–297.
- Kumakura S, Ishikura H, Kondo M, et al. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol. 2004;14(3):205–215.
- Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines. 2021;9(5):435.
- de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, et al. Urticarial vasculitis in COVID-19 infection: an a-vasculopathy-related symptom? J Eur Acad Dermatol Venereol. 2008;22(7):789–794.
- Gökce S, Dortkardesler BE, Aslan A. Normocomplementic urticarial vasculitis associated with a/H1N1 in a child case report. SN Comps Coin Med. 2020;25:1–3.
- Baigrie D, Bansal P, Crane JS. Leukocytoclastic vasculitis. Treasure Island (FL): StatPearls Publishing; 2020.
- Takao M, Hamada T, Kaji T, et al. Hypocomplementic urticarial vasculitis arising in a patient with immunoglobulin G4-relates disease. Int J Dermatol. 2016;55(4):430–433.
- Dash S, Behera B, Sethy M, et al. COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther. 2021;34(5):el5093.
- Wu V, Lopez CA, Hines AH, et al. Haemophagocytic lymphohistiocytosis following COVID-19 mRNA vaccination. BMJ Case Rep. 2022;15(3):e247022.
- Koga T, Sumiyoshi R, Furukawa K, et al. Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset still’s disease from sepsis. Arthritis Res Ther. 2020;22(1):108.
- Morimoto C. Effect of H1 histamine receptor antagonists on T cell functions. Arerugi. 2003;52(11):1039–1047.
- Murakami K, Houjo S, Tanaka K, et al. Cytokine storm and IL-6 amplifier. Inflam Immun. 2022;30(1):18–26.